Skip to main content
. 2022 Oct 17;10(10):e004973. doi: 10.1136/jitc-2022-004973

Figure 2.

Figure 2

Isolation and characterization of B16-F10 MHC-I peptides. (A) Schematic of the processes of generating tumor extracts, and isolation and identification of H2-Db and H2-Kb peptides. (B) The length distribution, the common motifs, and the total number of non-redundant peptides identified from either the H2-Db or H2-Kb MHC-I allele. (C) Schematic for selection of the tumor-specific peptides to be screened for T-cell reactivity by ELISpot. LC-MS, liquid chromatography coupled mass spectrometry; MHC, major histocompatibility complex.